To compare effect of Indrashani Choorna and Ferrous sulphate in patients having iron deficiency in blood sample.

Phase 2/3

Not yet recruiting

• Conditions: Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,

• Registration Number: CTRI/2022/11/047625
• Lead Sponsor: Dr Ritesh D Damle

Brief Summary

For the present study, Indrashani Choorna mentioned in Choorna chapter of Sahasrayoga, has been selected, which comprises of Tila, Pippali, Badara, Madhu, Makshika, Ayas, Shunthi and Sita. The research hypothesis is that, Indrashani choorna is helpful in the management of Panduroga with special reference to Iron deficiency Anaemia.

Expected outcome:• Significant improvement in subjective and objective parameters is expected in this comparative clinical study.• Jujube (Badara) was reported to contain numerous minerals. About 0.48 mg iron and 69 mg vitamin C per 100 g of fresh fruit were reported. Being intrinsically rich in potassium, phosphorus, manganese, iron, zinc these minerals help in maintaining cardiac health. Jujube is a great way to pump iron reserves, improve hemoglobin count and regulate thus, the daily intake of jujube could increase our dietary iron and vitamin, as to prevent anemia due to deficiency of iron or vitamin C.Hence, Indrashani choorna is expected to increase Hemoglobin level, significantly.• Since, Indrashani choorna is combination of indigenous compound drug, it is expected to get well tolerated and clinically safe and better alternative for ferrous sulphate which is having much adverse effect in management of IDA.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-12
• Last Update Posted: 2022-11-23

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 162

Inclusion Criteria

• 1. “Pandu Vyadhi†will be diagnosed on the basis of symptoms of Pandu Vyadhi. 2) Age: 18-60 Yrs. Irrespective of gender, religion, Socio.
• economic status, marital status. 3) Hb % more than 7 gm% & less than normal i.e. Male -< 13g / dl. And female -<12g/dl. 4) MCV less than normal. [80.
• 100 fl]. 5) PBS – Microcytic hypochromic (morphology) 6)Sr. Iron: below 70 mcg.

Exclusion Criteria

• 1. Known case of Endocrine disorders like Diabetes mellitus, hypothyroidism, Cushing syndrome, etc.
• 2. Pregnant and lactating lady.
• 3. Patient having Tuberculosis, known case of HIV, leprosy, any type of cancer.
• 4. Patient showing signs and symptoms of internal bleeding Haemorrhoids, menorrhagia etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To observe the changes in signs and symptoms of Pandu with use of Indrashani	At Day 0, Day 15th, Day 30th, Day 45
Choorna while comparing with ferrous sulphate.	At Day 0, Day 15th, Day 30th, Day 45

Secondary Outcome Measures

Name	Time	Method
To observe the changes in biochemical parameters in patients of Pandu Vyadhi with	the use of Indrasani Choorna while comparing with ferrous sulphate. (Hb, MCV,

Trial Locations

Locations (2)

Hospital of School of Ayurved; 🇮🇳 (Suburban), MAHARASHTRA, India

Sane Guruji Arogya Kendra; 🇮🇳 Pune, MAHARASHTRA, India

Hospital of School of Ayurved

🇮🇳(Suburban), MAHARASHTRA, India

Dr Ritesh D Damle

Principal investigator

9423569242

rritesh126@gmail.com